CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

Patients with Lewy body disease (LBD) often show a co-occurring Alzheimer disease (AD) pathology. CSF biomarkers allow the detection in vivo of AD-related pathologic hallmarks included in the amyloid-tau-neurodegeneration (AT(N)) classification system. Here, we aimed to investigate whether CSF bioma...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurology 2023-07, Vol.101 (1), p.e50-e62
Hauptverfasser:	Barba, Lorenzo, Abu-Rumeileh, Samir, Halbgebauer, Steffen, Bellomo, Giovanni, Paoletti, Federico Paolini, Gaetani, Lorenzo, Oeckl, Patrick, Steinacker, Petra, Massa, Federico, Parnetti, Lucilla, Otto, Markus
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged alpha-Synuclein Alzheimer Disease - pathology Amyloid beta-Peptides beta-Synuclein Biomarkers Female Humans Lewy Body Disease Male Middle Aged Neurogranin Retrospective Studies tau Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!